Abasys clinical research team is the best-in-class clinical expert, research staff and trained physicians all working together to help you get your products to the market, fast. Whether you need careful patient selection for your Phase 1 studies or experience in drug development and research for Phase II- IV operations, Abasys quality and performance will allow you to make a decision for your products.  With our clinical investigation sites in Bangalore, Mumbai, Delhi we will be able to provide patients for any type of disease trials be it oncology, heart disease or HIV/AIDs.

The Pharma giants (like Eli Lilly, Pfizer, Roche, Novartis, Glaxo-SmithKline) are magnetized by India is due to the fact that the country offers nearly 750,000 specialty hospital beds, 225 medical colleges and highly skilled English-speaking medical personnel. Eli Lilly the global pharmaceutical giant has 17 large and small clinical research projects running in 40 hospitals across India. In India 27 million have type-II diabetes, 12 million patients with psychiatric disorders, and about 30 million people with heart diseases.  An important reason for considering India for clinical trial is availability of man power at comparatively cheaper salaries. For instances a trial in United states can cost about %150 million while a similar drug trail in India would reduce the trial cost by 65%.

According to a Confederation of Indian Industry study, clinical trails in India in 2002 generated $75 million in revenues and it predicts that by 2007 it would grow to a 200$ million and by 2010 it will turn into a 1-1.5$ billion just for drug trials in the country.

Abasys with its ever-growing branches across the globe is planning to extend these clinical research trial facilities in other countries and continent. This is to provide a diversified and demographic dimension to your studies.